Concepedia

Dylan N. Adams

DN

5

Publications

881

Citations

5

H-Index

2018

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Broad Institute

University College London

Harvard University

Dylan N. Adams is an author at Dana-Farber Cancer Institute specializing in apoptosis, cell signaling, and tumor biology.

Top concepts

Publications per year

2018–2022

5

Publications

5

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms

Ofir Wolach, Rob S. Sellar, Kimberly Martinod et al. · Science Translational Medicine · 2018 · 435 citations · Full text

PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells

Josephine Kahn, Peter G. Miller, Alexander J. Silver et al. · Blood · 2018 · 213 citations · Full text

Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice

Emma C. Fink, Marie McConkey, Dylan N. Adams et al. · Blood · 2018 · 117 citations · Full text

Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs

Adam S. Sperling, Michael Burgess, Hasmik Keshishian et al. · Blood · 2019 · 59 citations · Full text

Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells

Rob S. Sellar, Adam S. Sperling, Mikołaj Słabicki et al. · Journal of Clinical Investigation · 2022 · 57 citations · Full text

, , +18

Rows per page

1–5 of 5